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   Amphotericin B， one of the polyene macrolide preparations， was administered to 10cases
of prostatic hyPertrophy associated with hypertension， cardiac insuthciency or diabetes mellitus
in a daily dose of 800一“1，200 mg for a period of ？．．tvlO weeks．
   Al／ of these case＄ were on conservative therapy． The object e£ the administration was to
study the effect of amphotericin B with respect to the reduction of adenoma， 1’mprovement of
clinical symptoms as ’翌?撃?as laboratory res’浮撃狽刀D
   As a result of the administratiori， marked reduction of adenoma was observed in one case，
rnoderate reduction in 5 and 3 showed little change in adenoma．
   Irnprovement of dysuria and frequency at night was noted in 7 cases， whereas 3 showed
・little change in・・the symptoms．
   Disapperance of residual urine was observed in 4， reduction ln 3， and the remaining 3
’showed little change in the symptoms． ・
   It can be said， consequently， that the administration of arnphotericin B produced marked
effect in one， effect・in 5， moderate effect in one and poor effect in 3．
  Orie of 5 cases showing effect was prostatectotnied thereafter for histological examination
which revealed the s！oughing of the glandular epithelium， dilated glandular lumen and granula－
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Table 2」血液所見
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式を推定している．
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 3） 血液所見（Table 2）
 fungizone投与前後の血液所見のうち血液一般では
Table 3 血液化学および肝機能その他





肝  機  能
GOT GPTτ雰酸フォ
血液電解質
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Table 4 Fungizone投与の効果
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